Hybrid interferons

Details Hybrid interferons Hybrid interferons

1986-06-05

1989-12-05

Hazel, Blondel

Drug, bio-affecting and body treating compositions

Lymphokine

Interferon

424 854, 530351, 43524027, 435320, 435 6951, A61K 4502, C07K 1300, C07K 1526, C12N 2100

Patent

active

048851663

ABSTRACT:
Novel hybrid interferons are produced which are derived from lymphoblastoid interferons .alpha.-2 and .alpha.-3 belonging to the interferon .alpha.B and .alpha.D groups, respectively. The novel hybrid interferons possess valuable antiviral and antiproliferative properties.

REFERENCES:
patent: 4414150 (1983-11-01), Goeddel
patent: 4456748 (1984-06-01), Goeddel
patent: 4569908 (1986-02-01), Mark et al.
patent: 4716217 (1987-12-01), Caruther et al.
P. K. Weck et al., Nucl. Acids Res., 9, 6153, (1981).
M. Weber et al., Nucl. Acids Res., 11, 5661, (1983).
M. Streuli et al., Proc. Natl. Acad. Sci. U.S.A., 78, 2848, (1981).
E. Rehberg et al., J. Biol. Chem., 257, 11497, (1982).
A. E. Franke et al., DNA, 1, 223, (1982).
Pestka, Archives of Biochemistry and Biophysics, vol. 221, No. 1, pp. 1-37, (1983).
Pestka, Scientific American, vol. 249, No. 2, pp. 29-35, (1983).
Chem. Abst., vol. 105:131876z, (1986).
Goodman et al., The Pharmacological Basis of Therapeutics, 7th Ed., Human Interferon, pp. 1233-1235.
Annual Reports in Medicinal Chem., 16, Pestka et al., Chapter 21, The Human Interferons, pp. 229-241, (1981).

Affiliated with

Also associated with

Rating

Hybrid interferons does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hybrid interferons, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybrid interferons will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2033506